Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Arcturus Therapeutics Inc.
DescriptionLUNAR-formulated mRNA targeting cystic fibrosis transmembrane conductance regulator (CFTR)
Molecular Target Cystic fibrosis transmembrane conductance regulator (CFTR)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: microRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today